|
Market Closed -
Nasdaq
03:00:00 07/11/2026 am IST
|
5-day change | 1st Jan Change | ||
| 0.6574 USD | -3.32% |
|
-7.66% | -42.33% |
| 26/10 | Top Premarket Gainers | MT |
| 12/10 | Iridex Says Glaucoma Therapy Lowers Eye Pressure, Reduces Medication Use | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Advanced Medical Equipment & Technology
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.15Cr | - | - | - | ||
| 26TCr | |||||
| 16TCr | |||||
| 16TCr | |||||
| 6.2TCr | |||||
| 5.87TCr |
- Stock Market
- Stocks
- IRIX Stock
- Charts IRIDEX Corporation
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
